Bahiru Goshu - PhD Student - University of Leipzig | LinkedIn
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
list of registered abstracts (sorted by category) - Universität Leipzig
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Research
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Wissenschaftlicher Mitarbeiter (m/w/d) Klinische Pharmakologie - Universität Leipzig, Medizinische Fakultät - academics
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Contents – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Achim Aigner - AD Scientific Index 2023
Universität Leipzig, Jahresbericht 2021
Współpraca międzynarodowa uniwersytetów to większe możliwości
Schlusswort
IJMS | Free Full-Text | SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells
Universität Leipzig, Jahresbericht 2021
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Analysis of polymeric nanoparticle properties for siRNA/DNA delivery in a tumor xenograft tissue slice air–liquid interface model - Karimov - 2023 - Biotechnology Journal - Wiley Online Library
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Aktuelles
Front Matter - 2021 - Computer Graphics Forum - Wiley Online Library
PEI-complexed LNA antiseeds as miRNA inhibitors
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in Oncology (12.05.2023)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
